Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia

NCT00142116 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Waldenstrom's Macroglobulinemia
Lymphoplasmacytic Lymphoma

Interventions

DRUG: Thalidomide
DRUG: Rituximab

Sponsor

Steven P. Treon, MD, PhD

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]